Nissan posts double-digit rise in quarterly operating profit

Nissan Motor reported a Q2 operating profit of 51.5 billion yen ($342 million), significantly exceeding analyst expectations and marking its best quarterly performance in over a year, primarily driven by cost reduction initiatives and robust North American sales. Despite this strong quarterly rebound, the company maintained its forecast for a 275 billion yen annual operating loss through March 2026, citing persistent headwinds from U.S. tariffs and supply chain risks, including a Nexperia chip shortage impacting Rogue SUV production. Concurrently, Nissan completed a 97 billion yen sale-and-leaseback transaction for its global headquarters.

Analysis

Nissan Motor reported a robust operating profit of 51.5 billion yen ($342 million) for the second quarter, significantly surpassing LSEG analyst expectations for a 70.9 billion yen loss and marking its strongest quarterly performance in over a year. This positive swing was primarily driven by successful fixed cost reduction initiatives under its turnaround plan and strong sales growth in North America.

Despite the impressive quarterly rebound, the company maintained its forecast for a 275 billion yen annual operating loss through March 2026. This cautious outlook reflects persistent macroeconomic headwinds, including U.S. tariffs and critical supply chain disruptions, notably a Nexperia chip shortage impacting production of its top-selling Rogue SUV.

Nissan's broader restructuring efforts include reducing global manufacturing plants from 17 to 10 and a 15% workforce reduction. Concurrently, the company completed a 97 billion yen sale-and-leaseback deal for its global headquarters, indicating proactive asset management to support its financial position.

Key Decisions for Investors

• Investors should closely monitor subsequent quarterly reports for evidence of sustained operational profitability and the effectiveness of ongoing cost reduction strategies.
• Assess Nissan's progress in mitigating supply chain vulnerabilities, especially the Nexperia chip shortage, and the impact of U.S. tariffs on its revised annual guidance.
• Evaluate the long-term financial implications of the headquarters sale-and-leaseback transaction on the company's balance sheet and operational flexibility.